NYSE:CIHealthcare
A Look At Cigna Group’s Valuation As Analysts Clash Over PBM Transition And Spending Uncertainty
Mixed analyst views put Cigna Group (CI) in focus
Recent analyst actions on Cigna Group (CI), including a downgrade tied to its pharmacy benefit manager transition and spending plans, along with a more constructive view from another firm, have pushed the stock back onto investor watchlists.
See our latest analysis for Cigna Group.
Cigna Group shares have been volatile, with a 3-month share price return of 3.33% and a 1-year total shareholder return that declined 7.76%. This suggests that...